As researchers are rediscovering the lost potential of psychedelic substances, it is emerging as a promising scientific field. These substances include classical psychedelics such as psilocybin and DMT, along with non-classical psychedelics such as MDMA and Ketamine. Already, some of these substances show great promise in the treatment of mental illnesses such as PTSD, depression, anxiety, and addiction, and seem to be valuable tools for personal development and the study of the mind. However, our university curriculums are providing insufficient information about the scientific advancements within this field, which is believed will revolutionize mental health treatment and the way in which we study the mind. Therefore, the Psychedelic Science Collective was established provide education on this topic.